Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 Pandemic
In this period of global pandemic caused by SARS-Cov-2, it is of paramount importance to recognize all risk factors that may increase the likelihood of infection. In addition to the risk factors known as pre-existing diseases and old age, risk factors could be drug treatments for chronic diseases, s...
Saved in:
Main Authors: | Francesco Ferrara (Author), Priscilla Santilli (Author), Vilma D'Aiuto (Author), Antonio Vitiello (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Regional Anesthesia During the SARS-CoV2 Pandemic: Appraisal of Clinical, Pharmacological and Organizational Aspects
by: Gianluca Cappelleri, et al.
Published: (2021) -
Novel β-Coronavirus (SARS-CoV-2): Current and future aspects of pharmacological treatments
by: Nidhi Tiwari, et al.
Published: (2020) -
Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
by: Yukio Ago, et al.
Published: (2011) -
Commentary of the mRNA vaccines COVID-19
by: Antonio Vitiello, et al.
Published: (2021) -
Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
by: Antonio Vitiello, et al.
Published: (2021)